Introduction
Isolates of corynefonn gram-positive rods often present difficulties in identification for diagnostic laboratories. One common strategy is to use API CORYNE strips (bioMerieux, Lyon, France) in which a series of 20 biochemical reactions are interpreted with the use of a database. Unfortunately, the discriminating power of this system is limited. This study reports the isolation of an organism from a patient which was identified by this system as ' Corynebacterium aquaticum'. Subsequent phylogenetic analysis revealed that the organism was in fact similar to Aureobacterium liquefaciens, although there were some phenotypic features which militated against this identification.
Only a small number of 'C. aquaticum' infections has been described, many of which may have been Aureobacterium infections. Only two detailed clinical descriptions of Aureobacterium infections have been published, although a larger number of clinical isolates have been examined microbiologically. The clinical aspects of these patients and developments for improving microbiological diagnosis are reviewed.
A 68-year-old man presented with febrile neutropenia in April 1998. He had been diagnosed 9 years earlier as having multiple myeloma and received treatment with six cycles of chemotherapy. Two years later he relapsed and was treated with high dose cyclophosphamide therapy followed by rescue stem cell transplantation. He remained well until 1997 apart from a severe episode of balanitis. In the same year he received another course of six cycles of chemotherapy for rising paraprotein levels which was complicated by an episode of pneumococcal sepsis. In March 1998 he was admitted for insertion of a central venous catheter and initiation of another course of chemotherapy, this time with a combination of etoposide, vincristine, doxorubicin and dexamethasone for 3 days followed by a single dose of cyclophosphamide. Twelve days after the second cycle of chemotherapy he was admitted with febrile neutropenia. At this time his total white cell count was 0. . Microbiological examination of urine was negative and a chest radiograph showed no evidence of pulmonary disease. Citrobacter freundii was grown from two sets of blood cultures taken on the day of admission. The next day six sets of blood cultures taken at different times through two lumina of the central venous catheter all yielded growth of a gram-positive bacillus reported as ' Corynebacterium aquaticum'. Initially the patient was treated empirically with ceftazidime and gentamicin. After 3 days, the ceftazidime was changed to imipenem; vancomycin was added on day 6 and his temperature settled 3 days later. He was discharged from hospital after 8 days, but was re-admitted 6 days later with another episode of febrile neutropenia. On this occasion, he was given vancomycin and ciprofloxacin empirically. Enterobacter cancerogenus was grown from blood cultures and the central venous catheter was removed. His temperature settled and he was discharged after 3 days.
Laboratory data
The isolates of Cit. freundii and E. cancerogenus were identified by the Vitek Automicrobic System (bioM6r-ieux, Hazelwood, MI, USA). A report of 'C. aquaticum' was issued initially on the basis of the identification provided by the API CORYNE system, version 1.1 (bioMerieux, Lyon, France). This organism was motile and colonies produced a yellow pigment after incubation for 3 days on blood agar. It was lactose non-fermenting on MacConkey agar. Some biochemical reactions are listed in Table 1 . In addition, it gave positive results for tyrosine hydrolysis, production of pyrrolidonyl arylamidase, alkaline phosphatase, galactosidase, glucosidase and pyrazinamidase, but negative results for hydrolysis of xanthine, hypoxanthine and adenine, fermentation of mannitol, xylose and ribose, and glucuronidase production. In view of the uncertain identification and the fact that a similar case had been reported from Adelaide [5] , an attempt was made to identify the organism by phylogenetic analysis.
A 1333-bp fragment of the 16s rRNA was sequenced following 'heat lysis' DNA extraction and gene amplification [6] with dye terminator chemistry (Per- Table 1 . Motility and biochemical reactions of the study organisms (adapted from kin-Elmer, Applied Biosystems Division, Foster City, CA, USA) as described previously [7] , but with the following primers: forward primer, 5'-GGCTCA-GATTGAACGCTGGCGG-3 ' ; reverse primer, 5 -ACCCACTCCCATGGTGTGACGG-3 ; reverse primer, 5 -TGTTACCGACTTTCATGACTTGACGG-3 '. The forward primer was used with each of the reverse primers to produce and sequence two amplicons, and a contiguous sequence was constructed with the GeneCompar program (Applied Maths, Kortrij k, Belgium). A Basic BLASTn Search (National Center for Biotechnology Information, National Library of Medicine, Bethesda, MD, USA; http://www.ncbi.nlm.nih.-gov) was performed, followed by a comparison and alignment of sequences retrieved by the search with the GeneCompar program. The GenBank accession numbers for the 16s rRNA sequences were as follows: A . liquefaciens, X77444; A . keratanolyticum, Y14786; A. testaceum, X77445; Microbacterium lacticum, X7744 1 ; C. aquaticum, X77450. The sequence for 1333 bases is shown in Fig. 1 A. liquefaciens CGT CAAGTCAT GAAAGT CGGTAACACCTGAAGCCGGT GGCCTAACCCTT GT GGAGGGAG Clinical isolate 
Discussion
Identification of coyneform bacteria to genus, let alone species level, is complex and difficult [8] . The study isolate was identified as 'C. aquaticum' by the API CORYNE system. This grouping does not differentiate true C. aquaticum from a number of other bacteria, particularly various species of Aureobacterium.
The first description of 'C. aquaticum' was produced by Leifson in 1962 for gram-positive rods, isolated fi-om distilled water, which exhibited many of the characteristics of motile plant-pathogenic corynebacteria [9] . Funke and colleagues reported that of 11 clinical specimens identified tentatively as ' C. aquaticum', four strains were true C. aquaticum whereas seven were species of Aureobacterium on biochemical and peptidoglycan analysis [ 1 11 . They also commented that many species descriptions of Aureobacterium are based upon only one strain, so that phenotypic species level identification within this genus is almost impossible at present [8] . On the basis of ribosomal gene sequence analysis, the present isolate was most closely related to A. liquefaciens, with 99.5% identity. However, A. liquefaciens is recorded as being non-motile [l] . The isolate in the present study is motile and has a very long single polar flagellum (Fig. 2) . On the other hand, the limited biochemical parameters were consistent with A. liquefaciens apart from hydrolysis of starch. Identification of coryneform bacteria to species level is valuable to detect and describe new species and to ascribe potential pathogenicity to species thought previously to be non-pathogenic. This is difficult for most routine diagnostic laboratories to perform with the tools generally available. The API CORYNE system version 1.1 labels C. aquaticum and a number of other organisms, including species of Aureobacterium, as ' C.
aquaticum'. A recent multicentre study has reported the result of classifying 407 strains of coryneform bacteria with the same biochemical system but with an updated and extended database, version 2.0 [12] . This database provided an improved overall performance and now divides 'C. aquaticum' into C. aquaticum and Aureobacterium species. Although Aureobacterium species are identified to genus level, the authors state that it is most unlikely that there will ever be a commercial identification system with a reliable database for these organisms. Therefore, organisms such as the present isolate will continue to require extended characterisation.
There are nine reports in the literature of patients infected with 'C. aquaticum' (Table 2) , although some of these are likely to have been Aureobacterium infections. Most adult patients had an underlying chronic disease -particularly diabetes, renal disease or a haematological disorder. The most common presentation was with cellulitis, although two patients undergoing chronic ambulatory dialysis had peritonitis and one patient had a localised infection following a high-pressure water injury. A wide range of antibiotics were tried -including first-, second-and thirdgeneration cephalosporins, penicillin, vancomycin and various aminoglycosides. All patients responded, although one patient had multiple relapses and another required removal of a peritoneal catheter. Antibiotic susceptibility patterns were measured by disk diffusion, E test or unstated methods, but these are difficult to interpret because there are no generally accepted criteria for breakpoints.
As the genus Aureobacterium has been described relatively recently and in view of the difficulty of making a bacteriological identification, there appear to have been only three reports in which clinical details have been provided ( Table 3 ). All three patients had bacteraemia and one patient also had severe cellulitis. One patient was on haemodialysis and another had acute leukaemia. Various cocktails of antibiotics were given, but two of the three patients died. The patient reported here fits with this general pattern. He was an elderly man with underlying myeloma who developed febrile neutropenia in the context of polymicrobial infections. The organism was isolated on multiple occasions from blood drawn through a central venous catheter, suggesting colonisation of the catheter with bacteraemia. He responded to combination antibiotic therapy. In addition to these detailed reports, Funke et al. indicated that the 11 isolates in their taxonomic study were obtained from blood (4) , soft tissues (2) , maxillary sinus (l), drain (l), cerebrospinal fluid (l), peritoneal fluid (1) and an epidural abscess, but clinical details were minimal [ 1 11 .
